Evidence map›Paper›PMID 33799617›Full record

ReviewCancers2021

Image-Guided Brachytherapy for Salvage Reirradiation: A Systematic Review.

Sophie Bockel, Sophie Espenel, Roger Sun, Isabelle Dumas, Sébastien Gouy, Philippe Morice, Cyrus Chargari

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07667192 (REGYNERA), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07667192 recruitingnot on this mapstarted 2026, after this paper: background citation

REGYNERA(Dia)TION: An Ambispective International Multicenter Patient Registry of Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Malignancies

Typeobservational_patient_registrySponsorAffidea Nu-med Center of Oncological DIagnostics and TherapyRan2026 to 2036Enrolled500ConditionsRecurrent Gynecologic Cancer, Recurrent Uterine Cancer, Recurrent Cervical Cancer, Recurrent Vaginal CancerArmsReirradiation, Total Ablative Strategy
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Spanish Society for Radiation Oncology and Spanish Society of Medical Physicists recommendations on reirradiation in gynecological cancer: reirradiation techniques, survival outcomes, dose, and toxicity.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Guideline
  2. Review
  3. Article
  4. Hsa_circ_0101308 adjusted by N6-methyladenosine (mCancer biomarkers : section A of Disease markers · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Radiation therapy for vulvar cancer: consensus technical guidelines of the GINECOR working group of the Spanish Society of Radiation Oncology. Part 2: radiotherapy recommendations.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  10. Recommendations of the Spanish brachytherapy group of the Spanish Society of Radiation Oncology and the Spanish Society of Medical Physics for interstitial high-dose-rate brachytherapy for gynaecologic malignancies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  11. Review
  12. Review
  13. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sophie BockelDepartment of Radiation Oncology, Gustave Roussy, Paris-Saclay University, 94800 Villejuif, France.
Sophie EspenelDepartment of Radiation Oncology, Gustave Roussy, Paris-Saclay University, 94800 Villejuif, France.
Roger SunDepartment of Radiation Oncology, Gustave Roussy, Paris-Saclay University, 94800 Villejuif, France.ORCID 0000-0001-9866-6449
Isabelle DumasDepartment of Radiation Oncology, Gustave Roussy, Paris-Saclay University, 94800 Villejuif, France.
Sébastien GouyDepartment of Surgery, Gustave Roussy, Paris-Saclay University, 94800 Villejuif, France.
Philippe MoriceDepartment of Surgery, Gustave Roussy, Paris-Saclay University, 94800 Villejuif, France.
Cyrus ChargariDepartment of Radiation Oncology, Gustave Roussy, Paris-Saclay University, 94800 Villejuif, France.ORCID 0000-0003-0119-3695
Université Paris-Saclay · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLocal recurrence in gynecological malignancies occurring in a previously irradiated field is a challenging clinical issue. The most frequent curative-intent treatment is salvage surgery. Reirradiation, using three-dimensional image-guided brachytherapy (3D-IGBT), might be a suitable alternative. We reviewed recent literature concerning 3D-IGBT for reirradiation in the context of local recurrences from gynecological malignancies.

methodsWe conducted a large-scale literature research, and 15 original studies, responding to our research criteria, were finally selected.

resultsLocal control rates ranged from 44% to 71.4% at 2-5 years, and overall survival rates ranged from 39.5% to 78% at 2-5 years. Grade ≥3 toxicities ranged from 1.7% to 50%, with only one study reporting a grade 5 event. Results in terms of outcome and toxicities were highly variable depending on studies. Several studies suggested that local control could be improved with 2 Gy equivalent doses >40 Gy.

conclusionIGBT appears to be a feasible alternative to salvage surgery in inoperable patients or patients refusing surgery, with an acceptable outcome for patients who have no other curative therapeutic options, however at a high cost of long-term grade ≥3 toxicities in some studies. We recommend that patients with local recurrence from gynecologic neoplasm occurring in previously irradiated fields should be referred to highly experienced expert centers. Centralization of data and large-scale multicentric international prospective trials are warranted. Efforts should be made to improve local control while limiting the risk of toxicities.

Indexed as

brachytherapycervical cancerendometrial cancergynecologic cancerradiotherapyreirradiationvaginal cancervulvar cancer

Identifiers

PMID33799617
PMCPMC7999189
OpenAlexW3135000249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.